
Vagbod 0.3 Tablet
Marketer
Kenriz Care
Salt Composition
Voglibose (0.3mg)
Overview Vagbod 0.3 Tablet
Diabeva 0.3mg tablets are indicated for managing type 2 diabetes. This medication assists in regulating postprandial hyperglycemia (high blood sugar after meals), particularly when dietary modifications and other antidiabetic agents prove insufficient. Diabeva 0.3mg should be administered immediately prior to each meal. Dosage and frequency are determined individually by your physician to optimize glycemic control. Discontinuation should only occur under medical supervision, as abrupt cessation may result in elevated blood glucose levels and increase the risk of complications, including renal impairment and vision loss. This medication forms part of a comprehensive diabetes management plan, which should also encompass a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is crucial while using Diabeva 0.3mg. Commonly reported side effects include abdominal distension, gastrointestinal discomfort, anorexia, constipation, and diarrhea. Consult your physician regarding any persistent or bothersome side effects. While Diabeva 0.3mg itself does not induce hypoglycemia, concomitant use with other antidiabetic agents (especially insulin or sulfonylureas) may increase this risk. Treatment for hypoglycemic episodes requires plain glucose; table sugar is ineffective. Prior to commencing treatment, inform your doctor of any liver or kidney conditions. This medicine is contraindicated in patients with bowel inflammation or ulceration (e.g., Crohn's disease, ulcerative colitis). Pregnant or lactating women should seek medical advice before use. Always disclose all current medications to ensure safe usage. Excessive alcohol consumption should be avoided due to a potential increased risk of hypoglycemia.
Primary Ingredients of Vagbod 0.3 Tablet
No text provided. Please provide the text you wish to be rephrased.
Uses of Vagbod 0.3 Tablet
Managing type 2 diabetes
Major Benefits of Vagbod 0.3 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Vagbod 0.3 Tablet on an empty stomach.
Common Side effects of Vagbod 0.3 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Vagbod 0.3 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Vagbod 0.3 Tablet. Ingest the tablet whole; do not crush, chew, or break it. Administer this medication on an empty stomach.
How Vagbod 0.3 Tablet works:
Vagbod 0.3 Tablets function as an antidiabetic agent by suppressing the activity of intestinal enzymes that digest complex carbohydrates into simpler sugars like glucose. This action helps to control postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vagbod 0.3 Tablet and alcohol is not advisable due to safety concerns.
PregnancySAFE IF PRESCRIBED
The medication Vagbod 0.3 Tablet is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Vagbod 0.3 Tablet while breastfeeding appears to be safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Vagbod 0.3 Tablet.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Vagbod 0.3 Tablets. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Vagbod 0.3 Tablet cautiously, potentially requiring a modified dosage. Physician consultation is advised.
What if you forget to take Vagbod 0.3 Tablet :
Omit any missed Vagbod 0.3 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Vagbod 0.3 Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |
